Tag: pharmaceuticals
ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors t…...
NEW YORK, Aug. 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of...
APELLIS PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LO… – Press...
NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 2, 2023 to...
Citius Pharmaceuticals, Inc. Receives a Complete Response Letter from the U.S....
No clinical efficacy or safety issues raisedCitius committed to working toward approvalCRANFORD, N.J., July 29, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or...
Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering – Tonix...
CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. TNXP ("Tonix" or the "Company"), a biopharmaceutical company, today announced...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Inves… –...
WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of...
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Pha… – Press...
Topline results from INTERCEPT-AD trial met primary and secondary objectives, demonstrating proof-of-mechanism for ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibodyRapid, dose-related,...
Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketi… –...
Amylyx will seek re-examination of its Conditional Marketing Authorisation Application
Amylyx Pharmaceuticals, Inc. AMLX ("Amylyx" or the "Company") today announced that the Committee for...
NovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products...
NovaBay® Pharmaceuticals, Inc. NBY, a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that it will showcase its Avenova®-branded...
Marinus Pharmaceuticals Further Strengthens Board of Directors with Appointment … –...
Marinus Pharmaceuticals, Inc. MRNS, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of...
Sparrow Pharmaceuticals Presents ePoster on SPI-62 at the 25th European Congress…...
Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today presented an...